The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial.
Pablo Garcia-ManauManel MendozaErika BonacinaRaquel Martin-AlonsoLourdes MartinAna Maria Palacios-MarquesMaria Luisa SanchezCristina LesmesIvan HurtadoEsther PerezAlbert Tubau NavarraPatricia IbañezMarina AlcozNuria ValiñoElena MorenoCarlota BorreroEsperanza GarciaEva Lopez-QuesadaSonia DiazJosé Román Broullón MolanesMireia TeixidorCarolina ChulillaMaría Del Mar GilMonica LopezAmparo Candela-HidalgoAndrea Salinas-AmorosAnna MorenoFrancesca MorraOscar VaquerizoBeatriz SorianoMarta FabreElena Gomez-ValenciaAna CuiñaNicolas AlayonJosé Antonio Sainz BuenoAngels VivesEsther EsteveVanesa OcañaMiguel Ángel LópezAnna MarotoElena Carreras MoratonasPublished in: JMIR research protocols (2022)
DERR1-10.2196/37452.
Keyphrases
- randomized controlled trial
- study protocol
- open label
- phase iii
- phase ii
- clinical trial
- birth weight
- double blind
- gestational age
- preterm infants
- phase ii study
- pregnant women
- cross sectional
- pregnancy outcomes
- blood flow
- squamous cell carcinoma
- body mass index
- adverse drug
- emergency department
- radiation therapy
- systematic review
- physical activity
- adipose tissue
- electronic health record
- drug induced